pillbase.ru

Sogroya

Active substance: somapacitan

somapacitan

Centralised EU authorisationActive

Marketing holder: Novo Nordisk A/S

Verified 2026-10-09 · EMA

Analogues in other countries
Composition
Analogues by country

Products with the same active substance registered in other countries.

CountryProducts
US 3
  • SOGROYA
    INJECTION, SOLUTION · SOMAPACITAN 6.7 mg/mL
    0169-2030
    Novo Nordisk
  • SOGROYA
    INJECTION, SOLUTION · SOMAPACITAN 10 mg/mL
    0169-2037
    Novo Nordisk
  • SOGROYA
    INJECTION, SOLUTION · SOMAPACITAN 3.3 mg/mL
    0169-2035
    Novo Nordisk
Import and control

Control by country

  • United Statesprescription only

    Source: openFDA NDC · record 01a1208c-5c3b-765c-99f5-9f748b16615e,01a1208d-18d4-7716-83d8-16d1170e8fba,01a12098-6eea-7781-babb-722710d51409;count=3 · valid from 2026-10-09 · verified 2026-10-09

More on control status
Registration
Registration number
EMEA/H/C/005030
Registration status
Active
ATC code
H01AC07
Sources
  • product · EMA · EMEA/H/C/005030 · Verified 2026-10-09
  • registration_status · EMA · EMEA/H/C/005030 · Verified 2026-10-09
  • ingredients.0 · EMA · EMEA/H/C/005030 · Verified 2026-10-09